⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Recover Losses - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
SPRY ALERT: Securities Fraud Class Action Launched Against ARS Pharmaceuticals, Inc. - October 5, 2026 Deadline
accessnewswire.com
SPRY
SPRY Investor Alert: ARS Pharmaceuticals Inc. Securities Class Action Notice - Contact SueWallSt
prnewswire.com
SPRY
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
SPRY
Shareholders of ARS Pharmaceuticals, Inc. (SPRY): Protect Your Rights Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY
prnewswire.com
SPRY
AI Disrupts Topical Drug Delivery as Billion-Dollar Partnerships and $3.3 Billion in VC Funding Signal a Structural Shift in Pharmaceutical Formulation
globenewswire.com
LLY
RXRX
NVDA
NVS
SNY
SPRY